A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo
Open Access
- 2 April 2007
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 117 (4), 1008-1018
- https://doi.org/10.1172/jci28920
Abstract
The tumor suppressor p53 is a potent inducer of tumor cell death, and strategies exist to exploit p53 for therapeutic gain. However, because about half of human cancers contain mutant p53, application of these strategies is restricted. p53 family members, in particular p73, are in many ways functional paralogs of p53, but are rarely mutated in cancer. Methods for specific activation of p73, however, remain to be elucidated. We describe here a minimal p53-derived apoptotic peptide that induced death in multiple cell types regardless of p53 status. While unable to activate gene expression directly, this peptide retained the capacity to bind iASPP — a common negative regulator of p53 family members. Concordantly, in p53-null cells, this peptide derepressed p73, causing p73-mediated gene activation and death. Moreover, systemic nanoparticle delivery of a transgene expressing this peptide caused tumor regression in vivo via p73. This study therefore heralds what we believe to be the first strategy to directly and selectively activate p73 therapeutically and may lead to the development of broadly applicable agents for the treatment of malignant disease.Keywords
This publication has 46 references indexed in Scilit:
- Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenograftsProceedings of the National Academy of Sciences, 2006
- p53 mutation heterogeneity in cancerBiochemical and Biophysical Research Communications, 2005
- 53BP2 induces apoptosis through the mitochondrial death pathwayGenes to Cells, 2005
- The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localizationOncogene, 2004
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- ApoptosisCell, 2002
- Evolution of Functions within the p53/p63/p73 FamilyAnnals of the New York Academy of Sciences, 2000
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993